Drug Type CAR-T |
Synonyms- |
Target |
Action modulators, inhibitors |
Mechanism PD-1 modulators(Programmed cell death protein 1 modulators), PSMA inhibitors(Prostate-specific membrane antigen inhibitors), Immunologic cytotoxicity |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Castration-Resistant Prostatic Cancer | Phase 1 | China | 23 Dec 2021 |





